The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2020 State Legislative Roundup: The Year That Could Have Been & the Year That Was

2020 State Legislative Roundup: The Year That Could Have Been & the Year That Was

August 21, 2020 • By Joseph Cantrell, JD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“The Year That Could Have Been” might be an apt title for any retrospective piece about 2020, but especially so regarding legislative affairs. Typically, years of work go into laying the foundation for policy change. Despite the focus on final votes, much of the work is done far in advance of those headline-grabbing roll calls. Days and nights spent away from families to build coalitions; in untold numbers of meetings with partners, legislators and the opposition;  and on phone calls—these countless hours of behind-the-scenes work are needed to move toward the single inflection point of pass or fail. That slow build is what makes 2020 so frustrating from a legislative perspective.

You Might Also Like
  • State Legislative Update: Setting the Stage for 2020 & Beyond
  • Early Activity Holds Signs of Hope for 2019 State Legislative Cycle
  • Active Advocacy in the Sunshine State: Florida Society Presses for Legislative Changes to Protect Patient Access to Medications
Also By This Author
  • Step Therapy Legislation in the States: Navigating a Varied & Complex System

Interrupted Sessions & Shifting Agendas
Going into the year, we were anticipating movement in states on many key issues, such as utilization management reform and pharmacy benefit manager (PBM) regulations. One hundred fifty-eight bills relating to PBM regulations, 61 on drug supply chain pricing transparency and 69 relating to coupons and cost sharing had been filed. The groundwork had been laid for 2020 to be a very important year for state legislative activity.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

However, those expectations were dashed as legislators shifted their focus to gaping budget holes, policy problems surrounding COVID-19, emergency licensing for healthcare providers and myriad other emergency items that no one anticipated late last year. Almost no area of life has been left untouched by COVID-19, and state legislative sessions were no exception.

Forty-two states experienced an interruption or delay in the legislative session stemming from concerns over the virus, and agendas shifted dramatically. Of the 69 coupon and cost sharing bills introduced, eight have been signed into law. Five of those only apply to insulin prescriptions. Of the 158 bills seeking new regulations on PBMs, only 19 have passed, with Georgia being the only state to pass something resembling the sweeping reform that was not uncommon only a year ago. And of the 61 transparency bills, only two have crossed the legislative finish line.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

There has been one bright spot of legislative activity. We were expecting to see as many as five states pass utilization management reform; to date three—Louisiana, North Carolina and South Dakota—have passed significant step therapy reform bills. We are still working to get step therapy reform passed in Massachusetts. We remain hopeful, although a victory is far from certain.

Outside step therapy, the remaining statistics reflect part of the extensive toll of COVID-19. The work, the energy and momentum to move pieces of legislation vanished in light of the health emergency, seemingly in an instant. Like many healthcare facilities, our legislatures were overwhelmed and consumed by the response to the pandemic.

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy Tagged With: Advocacy, Legislation, Pharmacy benefit manager reform, state legislation, step therapy legislation

You Might Also Like:
  • State Legislative Update: Setting the Stage for 2020 & Beyond
  • Early Activity Holds Signs of Hope for 2019 State Legislative Cycle
  • Active Advocacy in the Sunshine State: Florida Society Presses for Legislative Changes to Protect Patient Access to Medications
  • State Step Therapy Laws: Not All Are Created Equal

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.